Open Access

ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion

  • Authors:
    • Li Yang
    • Na Han
    • Xiaoxi Zhang
    • Yangmei Zhou
    • Rui Chen
    • Mengxian Zhang
  • View Affiliations

  • Published online on: April 2, 2020     https://doi.org/10.3892/or.2020.7573
  • Pages: 1831-1844
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma (GBM) is the most aggressive primary intracranial tumor in adults. Chemoradiotherapy resistance and recurrence after surgery are the main malignant progression factors, leading to a high mortality rate. Therefore, the exploration of novel biomarkers and molecular mechanisms of GBM is urgent. Differentially expressed genes (DEGs) of GBM were screened in a TCGA dataset. Homo sapiens ZW10 interacting kinetochore protein (ZWINT) was found to be upregulated in GBM, which was confirmed by immunohistochemical staining of a tissue microarray. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) database. A protein‑protein interaction (PPI) network was established by the STRING database, and hub genes were visualized by Cytoscape. The correlation results were verified with the GSE15824 dataset. Bioinformatic analysis confirmed that ZWINT was significantly positively correlated with kinetochore protein NDC80 homolog (NDC80), serine/threonine‑protein kinase PLK1 (PLK1) and spindle and kinetochore associated complex subunit 1 (SKA1) and together are involved in regulating mitosis and the cell cycle of GBM. ZWINT expression was knocked down in U251 and U87 MG GBM cells by lentiviral vectors carrying a small hairpin RNA (shRNA) targeting ZWINT. The effect of ZWINT silencing on cell proliferation, invasion and apoptosis was determined by the Celigo assay, MTT assay, Transwell assay, flow cytometry and caspase‑3/7 assay in vitro. A subcutaneous xenograft tumor model was established to explore the influence of ZWINT knockdown on GBM growth in vivo. Our preliminary study demonstrated that ZWINT knockdown effectively inhibited proliferation and invasion and induced apoptosis of GBM cells and notably suppressed GBM growth in vivo. Therefore, we speculate that ZWINT may be a potential therapeutic biomarker for GBM, with NDC80 and PLK1 conjointly involved in regulating cell division and the mitotic cell cycle.
View Figures
View References

Related Articles

Journal Cover

June-2020
Volume 43 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang L, Han N, Zhang X, Zhou Y, Chen R and Zhang M: ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Oncol Rep 43: 1831-1844, 2020
APA
Yang, L., Han, N., Zhang, X., Zhou, Y., Chen, R., & Zhang, M. (2020). ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Oncology Reports, 43, 1831-1844. https://doi.org/10.3892/or.2020.7573
MLA
Yang, L., Han, N., Zhang, X., Zhou, Y., Chen, R., Zhang, M."ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion". Oncology Reports 43.6 (2020): 1831-1844.
Chicago
Yang, L., Han, N., Zhang, X., Zhou, Y., Chen, R., Zhang, M."ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion". Oncology Reports 43, no. 6 (2020): 1831-1844. https://doi.org/10.3892/or.2020.7573